Navigation Links
DuPont Named to Biofuels Digest 2010 “Transformative Technologies 303

DuPont Collaborations with Key Partners Recognized

Wilmington, Del. (Vocus) June 22, 2010 -- All three DuPont biofuels collaborations received top honors in the 2010 “Transformative Technologies 30” survey, conducted by Biofuels Digest. The DuPont Danisco Cellulosic Ethanol (DDCE) joint venture and the DuPont partnership with Bio Architecture Lab (BAL) to develop macroalgae to butanol capabilities placed first, while the Butamax™ Advanced Biofuels joint venture placed second in their respective categories. The full results can be found here.

“DuPont is paving a new road for transportation fuels by delivering a portfolio of new biofuels technologies,” said DuPont Applied BioSciences President Craig F. Binetti. “Each venture incorporates game-changing science and tailored business models that maximize our ability to deliver large volumes of biofuels to a global population that is increasingly more interested in alternatives to oil.”

DDCE garnered the top ranking with 27.5 percent of the vote in the category: Transformative Technology: cellulosic ethanol – U.S. companies. The 50/50 joint venture of DuPont and Danisco has made rapid progress since it was established in 2008. DDCE has started up a 250,000-gallon demonstration-scale biorefinery in Tennessee and brought the cost of production below $2 per gallon. DDCE expects to announce its first commercial plans this fall.

“Cellulosic ethanol is ready for deployment,” Binetti said. With 28.6 percent of the vote in the biobutanol platforms category, the Butamax™ Advanced Biofuels joint venture was voted a clear leader in the development of biobutanol technologies.

“The strategic plan for Butamax™ is to give biorefineries the option to convert from ethanol to biobutanol in the future. The joint venture has started some preliminarily exploratory discussions with ethanol producers in the United States and Brazil,” Binetti said.

The U.S. Department of Energy Advanced Research Projects Agency – Energy (ARPA-E) awarded funding to DuPont and its partner BAL last fall to develop a process to convert macroalgae to biobutanol. The DuPont-BAL partnership placed first, garnering 52.2 percent of the vote in the category: Transformative Technology: macro algae platforms. “Macroalgae to biobutanol could reduce greenhouse gas emissions by more than 90 percent when compared to petroleum and diversify feedstock routes for advanced biofuels,” Binetti said.

Biofuels Digest readers submitted more than 48,000 votes from 3,500 ballots during the three-week voting process. The readers chose between transformative bioenergy technologies at more than 250 companies, universities and national laboratories, including 100 organizations that received write-in votes.

DuPont ( is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 90 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

Forward-Looking Statements: This news release contains forward-looking statements based on management’s current expectations, estimates and projections. The company does not undertake to update any forward-looking statements as a result of future developments or new information. All statements that address expectations or projections about the future, including statements about the company’s strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like “expects,” “anticipates,” “plans,” “intends,” “projects,” “indicates,” and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in DuPont’s filings with the Securities and Exchange Commission, particularly its latest annual report on Form 10-K, as well as others, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions of countries in which the company does business; competitive pressures; successful integration of structural changes, including acquisitions, divestitures and alliances; research and development of new products, including regulatory approval and market acceptance, and seasonality of sales of agricultural products.

Butamax™ is a trademark of Butamax™ Advanced Biofuels LLC, a BP-DuPont joint venture

# # #

Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. DuPont Leaders Brief Investors on Agriculture Businesses
2. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
3. DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration
4. DuPont Named Among Top Biotechnology Employers by Science Magazine
5. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize
6. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
7. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
8. DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences
9. DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum
10. DuPont and Precision BioSciences Collaborate to Accelerate Crop Product Development
11. Research Confirms Better Oil from New DuPont High Oleic Soybean Trait
Post Your Comments:
Related Image:
DuPont Named to Biofuels Digest 2010 “Transformative Technologies 303
(Date:10/13/2015)... , Oct. 13, 2015  Cepheid (Nasdaq: ... ending September 30, 2015. --> ... total revenue for the third quarter of 2015 is ... per share is expected to be approximately $(0.32) for ... non-GAAP net loss per share for the third quarter ...
(Date:10/13/2015)... CAMBRIDGE, Mass. , Oct. 13, 2015 ... quantitative methodologies at critical decision points throughout the drug ... at QSP Congress Boston 2015 on October 20-22, 2015 ... John Burke , PhD, Co-Founder, President, and CEO of ... drug discovery from early research to clinical trials" on ...
(Date:10/13/2015)... , October 13, 2015 ... and development company, has entered into a strategic relationship ... and Paris, France ... --> --> This collaborative arrangement gives ... respected scientific advisory team as well as long established ...
(Date:10/13/2015)... ... October 13, 2015 , ... Clinovo recently appointed Jeff Parr ... company’s fast growing clinical data solutions business. , Jeff Parr has spent the past ... sizes, including Avery Dennison, Thermo Fisher, and Ab Sciex to name a few. ...
Breaking Biology Technology:
(Date:10/12/2015)... Research and Markets ( ) ... Recognition Market by Component (Hardware & Software), Product ... Industry (Travel & Immigration, Military & Defense, & ... report to their offering. ... Market worth 3627.90 Million USD by 2020 ...
(Date:10/8/2015)... LAKE CITY , 8. Oktober 2015 ... TRCK), ein global tätiges Unternehmen des Bereiches ... einem Vertrag mit der Gefängnisbehörde Virginias (Department ... dessen Rahmen elektronische Überwachungsdienste für alle Strafen ... Derek Cassell , Präsident für den ...
(Date:10/7/2015)... NXTD ) ("NXT-ID" or the ... mobile commerce market and creator of the Wocket® smart ... long- term executive at American Express has been appointed ... ) ("NXT-ID" or the "Company"), a biometric authentication company ... of the Wocket® smart wallet announces Mr. Stanley ...
Breaking Biology News(10 mins):